Form DEFN14A - Definitive proxy statement filed by non-management:
SEC Accession No. 0001829126-22-014616
Filing Date
2022-07-25
Accepted
2022-07-25 14:04:51
Documents
2
Period of Report
2022-07-25

Document Format Files

Seq Description Document Type Size
1 DEFN14A titanpharma_defn14a.htm DEFN14A 323356
2 GRAPHIC img_001.jpg GRAPHIC 9859
  Complete submission text file 0001829126-22-014616.txt   338655
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 6502444990
TITAN PHARMACEUTICALS INC (Subject) CIK: 0000910267 (see all company filings)

EIN.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFN14A | Act: 34 | File No.: 001-13341 | Film No.: 221102786
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR. NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR. NEW YORK NY 10036 646 768 8417
Activist Investing LLC (Filed by) CIK: 0001817604 (see all company filings)

EIN.: 833953038 | State of Incorp.: NY | Fiscal Year End: 1231
Type: DEFN14A